Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
122 participants
OBSERVATIONAL
2009-04-30
2014-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
SurgiMend Mesh at the Hiatus
NCT04282720
A Prospective Case Series Evaluating Surgimend Mp® In Patients Undergoing Complex Abdominal Hernia Repair
NCT03450473
Observational Study to Evaluate Ventral Incisional Hernia Repair Using a Biologic Mesh (Cook Biodesign)
NCT02129140
Inguinal Hernia Study Using Biodesign IHM
NCT00393887
Mesh Type in Ventral Hernia Repair
NCT03091790
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Large abdominal hernia
* Inability to close the fascia primarily
* Contra-indication for the use of synthetic mesh
* Age \> 18 years
Exclusion Criteria
* Inability to close the skin over the SurgiMend 3.0
19 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Massachusetts General Hospital
OTHER
Boston Medical Center
OTHER
Cook County Hospital
OTHER
University of Southern California
OTHER
Yale University
OTHER
Oregon Health and Science University
OTHER
State University of New York - Upstate Medical University
OTHER
Integra LifeSciences Corporation
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
George C Velmahos, MD, Ph.D.
Role: PRINCIPAL_INVESTIGATOR
Massachusetts General Hospital/ Harvard University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Los Angeles County/University of Southern California Medical Center
Los Angeles, California, United States
Yale University School of Medicine
New Haven, Connecticut, United States
Cook County Hospital
Chicago, Illinois, United States
Massachusetts General Hospital
Boston, Massachusetts, United States
Boston Medical Center
Boston, Massachusetts, United States
State University of New York (SUNY), Upstate Medical Center
Syracuse, New York, United States
Oklahoma University
Oklahoma City, Oklahoma, United States
Oregon Health and Science University (OHSU)
Portland, Oregon, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
TEI-002
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.